ARCHIVED: MD Anderson names new vice provost, clinical and interdisciplinary research
MD Anderson News Release 06/30/2015
Â鶹ӳ» MD Anderson Cancer Center is pleased to announce the appointment of George Wilding, M.D., as vice provost for clinical and interdisciplinary research. Dr. Wilding¡¯s appointment at MD Anderson will begin on September 1st.?
Prior to joining MD Anderson, Dr. Wilding served on the institution¡¯s external advisory board. He also served as chair of the Moon Shots...
ARCHIVED: Similarities between embryos and breast tumors identified
MD Anderson researchers find that metastatic tumors behave like embryonic stem cells
MD Anderson News Release 06/30/2015
ARCHIVED: Keys to prevention: MD Anderson leaders share latest news in fight to end cancer
Making Cancer History? seminar returns to Aspen July 16
MD Anderson News Release 06/24/2015
Â鶹ӳ» MD...
ARCHIVED: Tiny particles in blood useful for early diagnosis of pancreatic cancer
MD Anderson study shows promise for Glypican-1 in identifying cancer-specific exosomes
MD Anderson News Release 06/24/2015
A protein encoded by the gene glypican-1 (GPC1) present on cancer exosomes may be used as part of a potential non-invasive diagnostic and screening tool to detect early pancreatic cancer, potentially at a stage amenable to surgical treatment, according to a study at Â鶹ӳ»...
ARCHIVED: Current blood cancer drug prices not justified, MD Anderson study finds
MD Anderson News Release 06/22/2015
The costs associated with cancer drug prices have risen dramatically over the past fifteen...
ARCHIVED: Genomic discovery of skin cancer subtypes provides potential ¡®signpost¡¯ for drug targets
MD Anderson researchers lead The Cancer Genome Atlas analysis of cutaneous melanoma identifying four subtypes
MD Anderson News Release...
ARCHIVED: Breast-Conserving Therapy for Early-stage Cancers has Increased Substantially, Though Access Remains an Issue
Largest, most in-depth study to date shows BCT is being used more widely; health policy interventions are needed to address factors that prevent...
ARCHIVED: What¡¯s in a name? ¡°Death-associated protein¡± promotes cancer growth in most aggressive breast cancers
MD Anderson study identifies DAPK1 protein as a novel therapeutic target in tumors with TP53 mutations
MD Anderson News Release 06...
ARCHIVED: ADAMTS family of genes may be the next ¡®thing¡¯ in ovarian cancer treatment
MD Anderson study reveals key mutations other than well-known BRCA1/BRCA2 genes
MD Anderson News Release 06/11/2015
ARCHIVED: MD Anderson study finds gene mutations sensitize tumors to specific cancer drugs
Commonly mutated tumor suppressor represents a new target for treating certain cancers
MD Anderson News Release 06/11/2015
</...